LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced an agreement with CeGaT, a leading, innovative laboratory in Germany that provides a wide array of molecular diagnostics tests. Under this agreement, N-of-One will provide clinical interpretation for CeGaT’s next-generation sequencing (NGS) tests done for cancer patients. Financial terms of the agreement are not disclosed.
Help employers find you! Check out all the jobs and post your resume.
